Buy Stocks Easy | About Us
January 26, 2022
Buy Stocks Easy | Online Stocks

DFFN


Buy Diffusion Pharmaceuticals Inc. Stock (symbol: DFFN) Easy Online

Company Name: Diffusion Pharmaceuticals Inc.

Symbol: DFFN

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2016

DFFN Current Share Price

Today's DFFN ( Diffusion Pharmaceuticals Inc. ) opening price: $0.3839

Yesterday's DFFN ( Diffusion Pharmaceuticals Inc. ) closing price: $0.3850

Diffusion Pharmaceuticals Inc. Stock ( symbol: DFFN ) Price Chart since IPO (2016):

12 Months Diffusion Pharmaceuticals Inc. Stock ( symbol: DFFN ) Price Chart

Popular Questions about Diffusion Pharmaceuticals Inc. Public Stock ( DFFN )

A: Diffusion Pharmaceuticals Inc. stock symbol (also called stock or share ticker) is DFFN

A: Diffusion Pharmaceuticals Inc. IPO (Initial Public Offering) took place on 2016

A: Diffusion Pharmaceuticals Inc.'s stock (DFFN symbol) price at ther IPO (initial Public Offering) was $0.3839

Q: Is DFFN stock worth buying at the moment?

A: The DFFN stock performance since 2019 are rather disappointing. If you had bought 1 share of Diffusion Pharmaceuticals Inc. stock (symbol: DFFN) at the beginning of 2019, at the opening share price of $2.2000, you would be left with exactly $0.3839 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Diffusion Pharmaceuticals Inc. Stock Easy Online

Diffusion Pharmaceuticals Inc. Stock Ticker Price Chart since IPO:





Diffusion Pharmaceuticals Inc. Stock Price Yesterday



 


Diffusion Pharmaceuticals Inc. Stock Price – Last Week




 


Diffusion Pharmaceuticals Inc. Stock Price – Last Month




 


Diffusion Pharmaceuticals Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/13/1960569/0/en/Diffusion-Pharmaceuticals-Inc-Announces-Closing-of-3-5-Million-Offering-Priced-At-the-Market.html
                            

                                
Diffusion Pharmaceuticals Inc. Announces Closing of $3.5 Million Offering Priced At-the-Market

                                
                                
CHARLOTTESVILLE, Va., Dec.  13, 2019  (GLOBE NEWSWIRE) -- Diffusion...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/12/1959966/0/en/CORRECTING-and-REPLACING-Diffusion-Pharmaceuticals-Inc-Announces-3-5-Million-Registered-Direct-Offering-Priced-At-the-Market.html
                            

                                
CORRECTING and REPLACING – Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market

                                
                                
CHARLOTTESVILLE, Va., Dec.  12, 2019  (GLOBE NEWSWIRE) -- In a rele...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/10/1958885/0/en/Diffusion-Pharmaceuticals-Presents-Data-Suggesting-Optimized-TSC-Dosing-Regimen-Increases-Survival-in-Newly-Diagnosed-Inoperable-Glioblastoma-Patients.html
                            

                                
Diffusion Pharmaceuticals Presents Data Suggesting Optimized TSC Dosing Regimen Increases Survival in Newly Diagnosed Inoperable Glioblastoma Patients

                                
                                
Presentation Made by Chief Scientific Officer John Gainer at the In...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/19/1949717/0/en/Diffusion-Pharmaceuticals-Presents-Early-Findings-Showing-Increased-Survival-in-Lead-in-Portion-of-Phase-3-Glioblastoma-Study-with-TSC-plus-Standard-of-Care.html
                            

                                
Diffusion Pharmaceuticals Presents Early Findings Showing Increased Survival in Lead-in Portion of Phase 3 Glioblastoma Study with TSC plus Standard of Care

                                
                                
Chief Scientific Officer Dr. John Gainer to Present at Inaugural Gl...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/15/1948133/0/en/Diffusion-Pharmaceuticals-Announces-Closing-of-4-0-Million-Public-Offering.html
                            

                                
Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering

                                
                                
CHARLOTTESVILLE, Va., Nov.  15, 2019  (GLOBE NEWSWIRE) -- Diffusion...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/13/1946432/0/en/Diffusion-Pharmaceuticals-Announces-4-0-Million-Public-Offering.html
                            

                                
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering

                                
                                
CHARLOTTESVILLE, Va., Nov.  13, 2019  (GLOBE NEWSWIRE) -- Diffusion...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/17/1931207/0/en/First-Patient-Enrolled-in-Diffusion-Pharmaceuticals-Phase-2-On-Ambulance-Clinical-Trial-with-TSC-for-the-Treatment-of-Stroke.html
                            

                                
First Patient Enrolled in Diffusion Pharmaceuticals’ Phase 2 On-Ambulance Clinical Trial with TSC for the Treatment of Stroke

                                
                                
CHARLOTTESVILLE, Va., Oct.  17, 2019  (GLOBE NEWSWIRE) -- Diffusion...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/03/1910181/0/en/Diffusion-Pharmaceuticals-to-Present-at-the-H-C-Wainwright-21st-Annual-Global-Investment-Conference.html
                            

                                
Diffusion Pharmaceuticals to Present at the H.C. Wainwright 21st Annual Global Investment Conference

                                
                                
CHARLOTTESVILLE, Va., Sept.  03, 2019  (GLOBE NEWSWIRE) -- Diffusio...


                            

                        
                    

                


                            

                    


                        
                            https://www.forbes.com/sites/gurufocus/2019/03/08/4-stocks-join-ben-graham-net-net-screener-friday/
                            

                                
4 Stocks Join Ben Graham Net-Net Screener Friday

                                
                                
Year to date, the market has gifted investors a 9.92% return, but i...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.